Stuttgart - Delayed Quote • EUR
Organigram Holdings Inc. (0OG0.SG)
As of 11:05 AM GMT+2. Market Open.
Loading Chart for 0OG0.SG
DELL
- Previous Close
1.6840 - Open
1.6720 - Bid 1.6680 x --
- Ask 1.7260 x --
- Day's Range
1.6460 - 1.6720 - 52 Week Range
0.9250 - 2.6200 - Volume
0 - Avg. Volume
1,683 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Jul 11, 2024 - Jul 15, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 0OG0.SG
Performance Overview: 0OG0.SG
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
0OG0.SG
30.63%
S&P/TSX Composite index
6.13%
1-Year Return
0OG0.SG
2.72%
S&P/TSX Composite index
8.93%
3-Year Return
0OG0.SG
79.34%
S&P/TSX Composite index
14.85%
5-Year Return
0OG0.SG
93.32%
S&P/TSX Composite index
36.59%
Compare To: 0OG0.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
1.6460
-2.26%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
8.45
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
10.72
-2.28%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
8.50
-0.58%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
10.74
-1.65%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
12.09
-0.17%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
10.73
-2.98%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
6.49
+6.05%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
8.30
+5.06%
Mkt Cap EUR 635.894M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 0OG0.SG
Valuation Measures
As of 5/14/2024
Market Cap
173.17M
Enterprise Value
144.56M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.24
Price/Book (mrq)
0.99
Enterprise Value/Revenue
1.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: 0OG0.SG
Company Insights: 0OG0.SG
0OG0.SG does not have Company Insights